When a Medicare Advantage member misses an annual wellness visit, the standard remedy is a call center agent dialing through a list. That single connected conversation can cost upwards of $5.63, according to a July analysis published by Rivvi's own technical team [Rivvi, July 2025]. Rivvi, a Boston-based startup founded in 2024, is betting that a voice agent can do the same job at a fraction of the cost while keeping the work inside the bounds of HIPAA and the Telephone Consumer Protection Act [Rivvi].
The patient population in question is broad: Medicare beneficiaries, commercial health plan members, pharmacy customers, and patients enrolled in life sciences programs. These are people who today receive a mix of robocalls, agent calls, text reminders, and patient portal messages from their providers and payers, often uncoordinated across systems. Standard of care for outreach in 2025 still leans heavily on outsourced call centers and rules-based IVR menus, supplemented by SMS reminders from electronic health record vendors. Closing a quality gap, confirming a refill, or scheduling a follow-up typically requires a human agent on the line, and staffing those agents has grown more expensive as health system margins have tightened.
Rivvi sells what it calls conversational AI infrastructure, a platform that handles patient communication across voice, text, and other channels on behalf of health systems, payers, pharmacies, government agencies, and life sciences companies [Rivvi]. The company describes its layer as sitting between fragmented patient data and the actual conversation, automating outreach while routing complex cases back to clinical staff [Rivvi]. Compliance is the wedge it leads with publicly: the platform is built to meet HIPAA requirements for protected health information and TCPA rules governing automated outbound calls [Rivvi].
The bet
Rivvi's pitch to a health plan is straightforward. Stars ratings, HEDIS measures, and quality bonus payments all hinge on whether members complete certain actions, from annual wellness visits to medication adherence checks. Reaching those members is a volume problem, and Rivvi's argument is that voice AI can place far more conversations per dollar than a contracted call center while staying within the regulatory perimeter [Rivvi]. The company reports having automated more than 2 million patient interactions and reached more than 500,000 patients to date [Rivvi].
Patient interactions automated | 2000000 | count
Unique patients reached | 500000 | count
Those figures come from the company's own about page and have not been independently audited [Rivvi]. The cost comparison Rivvi cites, $5.63 per successful live agent conversation, is drawn from its own technical blog rather than a peer-reviewed source [Rivvi, July 2025]. For a category that ultimately touches clinical outcomes, the absence of published outcomes data is the gap that matters most. Voice AI in Medicare outreach is still a young enough application that there is no established FDA pathway, since these tools are positioned as administrative communication rather than clinical decision support, but payers and health systems will increasingly want evidence that AI-driven outreach moves the metrics that matter: gap closure rates, completed appointments, refill adherence.
Why it could be big
The tailwinds are real. CMS has been tightening Stars methodology, and plans that lose a half-star can see hundreds of millions in bonus payments evaporate. Health systems coming out of the post-pandemic labor crunch are looking for ways to extend clinical and administrative staff without proportional hiring. And the underlying voice models have improved enough in the last 18 months that a patient on the other end of the line is less likely to immediately recognize a synthetic voice and hang up. Rivvi reports a 40 to 1 team use ratio internally, a figure the company uses to describe how its own small staff manages the platform [Rivvi].
The competitive set Rivvi will be measured against includes Vitraya, UnitedHealthcare's in-house engagement tooling, and Ayu Health, alongside a wider field of voice AI vendors targeting healthcare communication. UnitedHealthcare in particular is worth flagging: large payers building this capability internally is the structural risk for any vendor in the category.
The team
Rivvi was founded in 2024 by Nathan Hayman, who serves as Founder and CEO and whose background is in digital innovation and healthcare technology [LinkedIn]. Hayman is based in the Atlanta metropolitan area, while the company is headquartered in Boston [LinkedIn, 2026]. The company has not disclosed funding rounds or named investors publicly, and the founding team is structured around a solo founder.
The honest counterfactual
What bears will say is that voice AI for patient outreach is a crowded category where the incumbents include the payers themselves, and that Rivvi's published metrics, 2 million interactions, 500,000 patients, the per-call cost figure, all originate from the company [Rivvi]. What bulls will answer is that the regulatory framing matters more than the model. HIPAA and TCPA compliance are not features a generic voice AI vendor can bolt on after the fact, and a platform built from day one around protected health information and consented outbound calling has a defensible position when a compliance officer is in the buying committee [Rivvi]. The case studies Rivvi has published, including a patient engagement deployment it describes as achieving a 56 percent success rate, point to early customer traction even if the underlying contracts have not been named [Rivvi].
What to watch
The next 12 months should clarify three things. First, whether Rivvi names a marquee health system or payer customer, the kind of disclosure that converts company-reported interaction counts into a recognizable enterprise reference. Second, whether the company raises a priced round and discloses investors, which would put a market valuation on the conversational healthcare AI thesis. Third, whether Rivvi or a customer publishes outcomes data, ideally peer-reviewed or at least presented at a conference like HIMSS or AMCP, showing that AI-driven outreach actually moves Stars measures or HEDIS gap closure rates. For a company whose patients include Medicare beneficiaries managing chronic conditions, that evidence is what will separate an interesting infrastructure bet from a durable category.
Pulse Raman, Health and Bio Correspondent, Startuply.